Structure of S. agalactiae Toxin Identified
The overall structure of the group B streptococcus CAMP factor. Credit: JIN Tengchuan
Streptococcus (S.) agalactiae (contains the CAMP factor) is a round bacterium that could cause severe invasive infections. Biologists team led by Prof. JIN Tengchuan from University of Science and Technology of China of Chinese Academy of Sciences and Dr. Eric Brefo-Mensah from University of Waterloo revealed the structure of S. agalactiae CAMP factor and the mechanism behind for the first time. Research article was published in the Journal of Biological Chemistry on June 8th.
By utilizing X-ray diffraction technique, researchers reported the structural fold of S. agalactiae CAMP factor is composed of 5+3 helix bundles, where the N-terminal 5 helix bundle is believed to be responsible for membrane permeabilization and the C-terminal 3 helix bundle is likely responsible for host receptor binding. Besides, the C-terminal domain is revealed to inhibit the activity of both full-length toxin and its N-terminal domain.
The researchers also observed that the linker region has a conserved DLxxxDxAT sequence motif, which is required for CAMP factor's co-hemolytic activity. The results helped clarify the molecular mechanism of S. agalactiae's co-hemolytic activity.
What the researchers illustrated may assist to the screening of anti-CAMP virulent factor drugs and inspire more to reveal the nature of the interaction between proteins and biofilms.
This article has been republished from materials provided by University of Science and Technology of China. Note: material may have been edited for length and content. For further information, please contact the cited source.
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE
Working Together Helps Phage Overcome CRISPRNews
Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.READ MORE